Merit Medical Systems Inc (MMSI) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
Merit Medical Systems Inc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period
Return on Assets, Quarterly Results, Trends, Rankings, Statistics
What is Merit Medical Systems Inc's ROA in the third quarter of 2026? Merit Medical Systems Inc achieved a return on average assets (ROA) of 5.75 % in its third quarter of 2026, this is above MMSI's average return on assets of 3.05%. Merit Medical Systems Incs assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion
ROA has improved compared to 5.35% in the second quarter of 2026, due to net income growth.
However, within the Healthcare sector 142 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1130, from total ROA ranking in the second quarter of 2026 at 1379.
In a pivotal moment for Merit Medical Systems, Inc. the company has announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. This transition comes at a critical juncture as the company contemplates its strategic direction amidst mixed financial performance and a significant regulatory achievement.Despite Wright s departure, Merit Medical has reported a commendable return on assets (ROA) of 5.11% for the third quarter of 2024, well above its own historical average of 2.71%. However, this figure masks deeper concerns, as it represents a decline from previous quarters. Specifically, the company has faced a downturn in net income, which contributed to a drop in its ranking in the healthcare sector s return on assets, slipping from 1044 in Q2 2024 to 1053 now. Alarmingly, 117 other companies in the same sector boast higher ROA figures, suggesting that Merit Medical s market competitiveness may be waning.
Merit Medical Receives FDA 510(k) Clearance for SCOUT MD Surgical Guidance System Merit Medical Systems Inc, a leading manufacturer of medical devices, has recently announced that it has received FDA 510(k) clearance for its SCOUT MD Surgical Guidance System. This new guidance system is seen as a significant advancement in breast cancer care, as it allows for the precise excision of tumors by targeting their location in multiple dimensions. The SCOUT MD Surgical Guidance System aims to ensure successful surgeries and improve patient outcomes. The SCOUT MD Surgical Guidance System provides surgeons with real-time, intraoperative 3D information that assists in identifying the precise location of target tissues. This helps surgeons to more accurately plan and execute the removal of tumors during breast cancer surgeries. The system works by using a reflector that is placed in the breast tissue prior to surgery. The reflector can then be easily tracked using the SCOUT console, providing continuous guidance and feedback to the surgeon.
Comment on MMSI's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 4.78 %, despite annual net income growth of 6.76 % to $128.49 million, from $120.36 million a year ago, as MMSI's assets increase to $2,685.92 million, by 6.76 %.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
